Introduction
Leprosy is a disease which develops in a minority of those exposed to infection with Mycobacterium leprae. It probably affects about 12 million people world-wide, the vast majority living in the tropics. The disease presents with skin lesions and/or disorders of peripheral nerves in people who have lived for many years in endemic areas.
Patients
The 30 patients comprised 23 men and 7 women. All were born abroad and almost certainly acquired the infection in the place of origin which was the Indian subcontinent in 26 cases, the remainder coming from South Yemen, Singapore, Libya and Jamaica. Seven of the Indian patients were Gujeratis who had lived for several years Libya, one of the BL patients from Jamaica and one from South Yemen.
Bacilli were seen at presentation in skin smears from 10 patients (all those classified as LL, BL and BB and from two of those classified as BT).
Skin lesions. These were either macular or raised, the latter ranging from papules or nodules to more extensive plaques but in all patients the lesions were more or less discrete. Macular lesions were almost invariably less sensitive to pinprick than surrounding skin but, in about half the patients with raised lesions, sensation in affected areas was intact. The number and nature of the skin lesions accorded well with the other indices on which classification is based, tuberculoid patients having few lesions, usually macular and anaesthetic, while the number and elevation of lesions tended to increase towards the lepromatous pole.
Eight of the fourteen patients presenting with skin lesions were found to have a focus of neuropathy elsewhere. All 8 had borderline leprosy. In half, the neuropathy was purely sensory while the others were also found to have weakness of muscles supplied by the ulnar nerve (3) and median nerve (one).
Neuropathic presentation. The 11 patients with a neuropathic presentation sought advice because of ulceration or blistering secondary to sensory loss (6) or because of muscle weakness (5). In the sensory group, plantar ulceration was the most common symptom (4) while painless blistering of the hands was seen in 2. Four patients presented with clawhands from involvement of the ulnar nerve and 2 of these also had foot-drop from involvement of the lateral popliteal nerve. Foot-drop was the sole disability in two patients. All but 2 patients with a neuropathic presentation were found to have diagnostic skin lesions in the form of hypopigmented, hypoaesthetic macules. The 2 exceptions therefore exemplify pure neural leprosy.
Where neuropathy indicated involvement of a normally palpable peripheral nerve, the nerve was usually, but not invariably, enlarged or hardened. Conversely, thickened nerves were occasionally found with no evidence of loss of function.
Presentation with an unrelated condition. Five patients presented with an unrelated medical problem. In 3, the disease had already resolved spontaneously leaving some loss of skin sensation and one or more thickened peripheral nerves. These patients were given a course of dapsone as a precaution and are now under annual review.
Management and outcome
Until 1981, dapsone alone was usually given for at least 5 years to tuberculoid patients and for life to those with lepromatous disease. The emergence of dapsone-resistant strains of M. leprae led to the recommendation that all patients with leprosy should received combination chemotherapy (W.H.O., 1982). Patients with multibacillary disease now receive daily dapsone and clofazimine (Lamprene) with a single dose of rifampicin every month. This regime renders lepromatous patients non-infectious within 2 weeks and may allow treatment to be stopped after as little as 2 years. Tuberculoid patients receive daily dapsone and monthly rifampicin for 6 months. Patients are considered cured when they are free from reaction, skin smears are free of bacilli and they have received an appropriate course of chemotherapy. Cured patients are reviewed annually.
No patient with disease classified as BT or TT who has completed a course of dapsone has shown any sign of disease activity at follow-up. The lepromatous and borderline lepromatous patients are all receiving treatment at the time of writing.
Discussion
Despite the continuing and unnecessary stigma of leprosy, this disease does not appear to pose much risk to public health in modem Britain. Infectivity is greatest in bacilliferous patients and, in our group, most such patients were diagnosed by dermatologists who clearly have a high index of suspicion for the disease.
The population of the City of Birmingham in 1978 was just over one million and, in that year, it was estimated that 52000 residents were of West Indian ancestry and 70000 of Asian (City of Birmingham Central Statistics Office, 1979). The greater incidence of leprosy in Asian immigrants probably reflects a greater prevalence of the disease in the Indian subcontinent which in turn may reflect a greater susceptibility in Asians.
The relatively small proportion of patients who had bacilliferous disease contrasts with the situation in the United States ofAmerica where there were 412 cases of leprosy notified from 1971 to 1973 inclusive, of whom 80 had never lived or travelled abroad (Centre for Disease Control, 1977) . Almost half of the total number had lepromatous disease and a substantial majority of the total were bacilliferous at presentation. Most of the American cases were in people of Spanish extraction which supports the contention that white Caucasians are more likely than Asian Indians to develop lepromatous disease, although early (indeterminate) and single-lesion selfhealing TT leprosy may easily escape diagnosis in pale-skinned patients. It is probable that most individuals infected with M. keprae will never develop the disease, whatever their race.
